drugset
drugset / Trial / NCT01094847

Clinical Trials to Compare Mosapride Bioavailability Between DWJ1252 and Mosapride Medicine

NCT01094847 ↗

Phase 1 Completed 30 enrolled Daewoong Pharmaceutical Co. LTD.
RandomizedCrossoverOpen-label

Summary

The purpose of this study is to compare and explore bioavailability of mosapride, the main component of DWJ1252(Test drug) and mosapride medicine(Reference drug).

Timeline

Start
2010-04
Primary completion
2010-05
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject DWJ1252 Unknown — Oral

Indications

No indication recorded.